The Nefkens Adrenal Cancer Foundation has been established in September 2024 to support innovative research into adrenocortical cancer (ACC) with clinical impact. On a regular basis funding in the form of grants will be provided. Until February 1th 2025 preproposals can be submitted for obtaining a clinical research grant or a translational research grant. See for more information www.nac.foundation.
The next annual joint ENSAT and COST Harmonisation meeting is scheduled for 3rd to 5th September 2025 in Belgrade (Serbia). Please SAVE THE DATE in your calendars. More details will be provided in the due course.
